AVEO Pharmaceuticals Inc

-0.33 (-5.77%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)185.27M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$22.95 Million
Adjusted EPS-$0.17
See more estimates
10-Day MA$6.15
50-Day MA$6.62
200-Day MA$6.87
See more pivots

AVEO Pharmaceuticals Inc Stock, NASDAQ:AVEO

30 Winter Street, 14th floor, Boston, Massachusetts 02108
United States of America
Phone: +1.617.400.0101
Number of Employees: 49


AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA.